Oct 2026· Frontiers in Immunology· Vol 17· 0 citations· 60 references
Medicine
TL;DR
It is demonstrated that soluble factors released from platelet concentrates can modulate inflammatory responses in platelet-depleted blood in an ex vivo setting, with context-dependent, bidirectional, and selective immunomodulatory effects.
Abstract
Introduction Platelets contain a wide range of bioactive mediators, many of which accumulate during storage of platelet concentrates and have immunomodulatory properties. Our objective was to investigate how mediators derived from stored platelet concentrates modulate the acute inflammatory response using an ex vivo model. Methods Platelet-depleted whole blood from healthy donors (n=8) was supplemented with pooled platelet concentrate supernatants generated from six platelet concentrates sampled on storage days 1, 3, 5, and 7, and incubated with or without heat-inactivated Escherichia coli for four hours at 37 °C. Inflammatory responses were assessed by measuring complement activation, platelet-derived mediators, and cytokines. Results In the absence of E. coli, addition of platelet concentrate supernatants increased the levels of 24 of 32 measured inflammatory mediators. In contrast, under E. coli-stimulated conditions, the supernatants increased 10 markers and attenuated 14 markers, including the key pro-inflammatory cytokines IL-1β, IL-6, and TNF. The attenuation of these cytokines ranged from 25-43%, whereas several other mediators were unchanged or increased. The majority of biomarkers showed limited differences across the investigated storage time points. Conclusions Our findings demonstrate that soluble factors released from platelet concentrates can modulate inflammatory responses in platelet-depleted blood in an ex vivo setting, with context-dependent, bidirectional, and selective immunomodulatory effects.
Platelet activation plays a central role in arterial thrombosis, thromboinflammation, and microvascular injury. Conventional platelet function tests evaluate platelet responsiveness to exogenous agonists ex vivo but do not directly reflect in vivo platelet activation. Although several soluble platelet-derived molecules...
K. Suzuki-Inoue, Makyo Ueda, Toshiaki Shirai et al.· Journal of Clinical Medicine· 0 citations
Platelets are essential to prevent blood loss and to orchestrate inflammation. Thrombotic complications of vascular disease and hyperresponsive platelets are associated with adverse outcomes, yet physiological mechanisms counteracting systemic platelet activation are poorly defined. In mice, we found that the spleen fi...
L. Laun, Alexander Leunig, Felix Zhang et al.· Science· 0 citations
The role of catecholamine excess in early platelet dysfunction following shock and its subsequent effects on platelet activation, aggregation, and adhesion in an in vitro model are supported and present possible therapeutic targets for future studies.
Lawrence N. Diebel, D. Liberati, Vanessa Anunobi· Surgery· 0 citations
To evaluate the anti-inflammatory and antioxidant effects of standard platelet-rich plasma (sPRP) and balanced protein-concentrate plasma (BPCP), which is a next-generation formulation enriched in platelet-derived and extraplatelet bioactive molecules, in an indirect co-culture model of primary human chondrocytes (hCh)...
Daniel Marijuan-Pinel, Jon Mercader-Ruiz, Xabier Sansinanea et al.· International Journal of Mol...· 0 citations
Neonatal and adult platelets are functionally different, with neonatal platelets being comparatively hypo-reactive to multiple platelet agonists. When transfused, neonates receive platelets from adult donors, resulting in a cellular developmental mismatch. Platelets are key regulators of the monocyte inflammatory respo...
Erin L. Soule-Albridge, Emily Flahardy, Henry A. Feldman et al.· Platelets· 0 citations